C
C. Noel Bairey Merz
Researcher at Cedars-Sinai Medical Center
Publications - 585
Citations - 42560
C. Noel Bairey Merz is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Coronary artery disease & Medicine. The author has an hindex of 79, co-authored 490 publications receiving 37090 citations. Previous affiliations of C. Noel Bairey Merz include University of Michigan & American College of Cardiology.
Papers
More filters
Journal ArticleDOI
Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
Thomas Rutledge,Thomas Rutledge,Tanya S. Kenkre,Vera Bittner,David S. Krantz,Diane V Thompson,Sarah E. Linke,Jo-Ann Eastwood,Wafia Eteiba,Carol E. Cornell,Viola Vaccarino,Carl J. Pepine,B. Delia Johnson,C. Noel Bairey Merz +13 more
TL;DR: Among women with signs and symptoms of myocardial ischemia, anxiety measures predict cardiac endpoints ranging from cardiac symptom severity to healthcare utilization, and anxiety may warrant greater consideration among women with suspected CAD.
Journal ArticleDOI
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.
Glenn D. Braunstein,B. Delia Johnson,Frank Z. Stanczyk,Vera Bittner,Sarah L. Berga,Leslee J. Shaw,T. Keta Hodgson,Maura Paul-Labrador,Ricardo Azziz,C. Noel Bairey Merz +9 more
TL;DR: Serum levels of androgens and estrogens track closely in postmenopausal women referred for coronary angiography for suspected myocardial ischemia, and highly significant correlations were found for total T, free T, and androstenedione with total E2, free E 2, bioavailable E2 and estrone and persisted after adjustment for BMI and insulin resistance.
Journal ArticleDOI
Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary study.
Cecil A. Rambarat,Islam Y. Elgendy,Eileen M. Handberg,C. Noel Bairey Merz,Janet Wei,Margo Minissian,Michael D. Nelson,Louise Thomson,Daniel S. Berman,Leslee J. Shaw,Galen Cook-Wiens,Carl J. Pepine +11 more
TL;DR: Symptomatic patients with CFR <2.5 and no obstructive CAD had improved angina and myocardial perfusion with ranolazine, supporting the hypothesis that the late sodium channel is important in management of coronary microvascular dysfunction.
Journal ArticleDOI
Coronary Microvascular Dysfunction Causing Cardiac Ischemia in Women
Journal ArticleDOI